The "golden window" for treatment was strictly limited to 4.5 hours. However, the 2026 guidelines introduce a more flexible approach based on advanced imaging.

Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health through anti-inflammatory, vascular, and neuroprotective mechanisms.

When someone walks into an emergency room with symptoms of a stroke, every second matters. But today, diagnosing the type of stroke, the life-or-death distinction between a clot and a bleed, requires ...

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and adults are among the major updates in the new 2026 Guideline for the Early ...

Overlooked or underestimated risk factors may warrant more consideration in stroke prevention and epidemiology, according to ...

Treatment of acute stroke, before a distinction can be made between ischemic and hemorrhagic types, is challenging. Whether very early blood-pressure control in the ambulance improves outcomes among ...

CHOICE-2 supports intra-arterial alteplase after successful reperfusion ...